Form 4: DarioHealth President Buys 40,000 Shares

DarioHealth Corp.'s President and CCO, Steven Charles Nelson, purchased 40,000 shares of common stock at $0.53 per share.

Summary

• Steven Charles Nelson, President and CCO of DarioHealth Corp., acquired 40,000 shares of the company's common stock.
• The transaction took place on August 27, 2025, with shares purchased at a price of $0.53 each.
• Following this acquisition, Mr. Nelson's beneficial ownership in DarioHealth Corp. common stock totals 95,000 shares.

Sentiment

Score: 7

Explanation: The President and CCO's purchase of a significant block of shares indicates strong insider confidence in the company's valuation and future prospects.

Positives

• President and CCO Steven Charles Nelson purchased 40,000 shares of common stock, signaling strong insider confidence in the company's future prospects.
• The acquisition price of $0.53 per share suggests management perceives value at the current stock price.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company.

Industry Context

This insider purchase reflects an individual executive's belief in the company's value, which can be a positive signal within the digital health and chronic disease management industry, where investor confidence in growth strategies is crucial.

Stakeholder Impact

• Shareholders may interpret the insider purchase as a positive indicator, potentially increasing confidence in the company's stock and future performance.

Key Dates

Recommendation

The significant purchase of common stock by a key executive, the President and CCO, at $0.53 per share, signals strong insider confidence in the company's current valuation and future growth trajectory. This direct investment aligns management's interests with shareholders and suggests a belief that the stock is undervalued.

Keywords

DarioHealth, DRIO, insider trading, stock purchase, Steven Nelson, common stock, officer, CCO, President